Skip to main content
Curcumin therapy for knee osteoarthritis

Curcumin is widely used in traditional Chinese medicine to treat arthritis an

Dr. John Cush RheumNow

2 years 7 months ago
Curcumin therapy for knee osteoarthritis Curcumin is widely used in traditional Chinese medicine to treat arthritis and is presumed to have analgesic and antiinflammatory effects that may benefit those with osteoarthritis, particularly KOA. https://t.co/0EmPrEZTce https://t.co/74uNQJ3a34
Enthesitis, Synovitis, and Tenosynovitis in Psoriatic Arthritis

An ultrasound study suggests that enthesitis is associ

Dr. John Cush RheumNow

2 years 7 months ago
Enthesitis, Synovitis, and Tenosynovitis in Psoriatic Arthritis An ultrasound study suggests that enthesitis is associated with both synovitis and tenosynovitis in patients with Psoriatic arthritis (PsA). https://t.co/fsVlUwOXCW https://t.co/1tLTlEoXd8
Experience the Future of Rheumatology at RheumNow Live 2024, just three weeks away!

Don't miss out – secure your spo

Dr. John Cush RheumNow

2 years 7 months ago
Experience the Future of Rheumatology at RheumNow Live 2024, just three weeks away! Don't miss out – secure your spot today for an unforgettable journey into the latest advancements and insights. https://t.co/HN8ErCpSMb https://t.co/kCYD7Hbhxx
Hydroxychloroquine for COVID may have caused 16,990 deaths. Systematic review of 44 cohort studies showed HCQ use in COV

Dr. John Cush RheumNow

2 years 7 months ago
Hydroxychloroquine for COVID may have caused 16,990 deaths. Systematic review of 44 cohort studies showed HCQ use in COVID was associated with 11% increase in mortality in 6 countries (US 12,739, Spain 1,895, Italy 1,822, Belgium 240, France 199,Turkey 95 https://t.co/vmhvSx4XLO https://t.co/KRxqiiSFC3
There is a dose, duration and recency-dependent relationship between previous GC use and MACE. GC doses 5mg/day, duratio

Dr. John Cush RheumNow

2 years 7 months ago
There is a dose, duration and recency-dependent relationship between previous GC use and MACE. GC doses 5mg/day, durations of 30 days, and use one year prior to MACE were all associated with an increased risk of MACE, Wallace B Abst#2430 #ACR23 #ACRBest https://t.co/VOUmsvAs2r https://t.co/LKtuuoD3xa
Biomarker Predicts Survival in Autoimmune Lung Disease

One major subgroup of patients with ILD arising from polymyosit

Dr. John Cush RheumNow

2 years 7 months ago
Biomarker Predicts Survival in Autoimmune Lung Disease One major subgroup of patients with ILD arising from polymyositis/dermatomyositis (PM/DM) survived significantly longer when serum levels of interferon-λ3 were relatively low, researchers found. https://t.co/2nYPBbNfCh https://t.co/n2Llxb7tdx
Anti-TNF mAbs, JAKi & anti-IL17 Rx appear protective against anterior Uveitis in AxSpA pts. Network Metanalysis of 4

Dr. John Cush RheumNow

2 years 7 months ago
Anti-TNF mAbs, JAKi & anti-IL17 Rx appear protective against anterior Uveitis in AxSpA pts. Network Metanalysis of 44 trials, AU IR -TNF mAb: 4.1, ETN: 5.4, IL17i: 2.8, JAKi: 1.5, & placebo: 10.8. AU risk: TNFi < JAKi < IL-17i < ETN << PBO https://t.co/3zIcvuIaBV https://t.co/UseZ6t00EB
Congratulations to Professor Paul Emery OBE on being named CBE: Commander of the Most Excellent Order of the British Emp

Dr. John Cush RheumNow

2 years 7 months ago
Congratulations to Professor Paul Emery OBE on being named CBE: Commander of the Most Excellent Order of the British Empire for his research and advances in rheumatology. He is the Versus Arthritis Professor of Rheumatology, Leeds Institute https://t.co/27igYiQxna https://t.co/KcQk5LasfN
AutoAbs in poly/dermatomyositis - ANA+ 50% to 80%, but not helpful in Dx. Look for MSA Abs - espec antisynthetase ABs (a

Dr. John Cush RheumNow

2 years 7 months ago
AutoAbs in poly/dermatomyositis - ANA+ 50% to 80%, but not helpful in Dx. Look for MSA Abs - espec antisynthetase ABs (anti-Jo-1), but also newer Abs: MDA-5, TIFF-1 gamma, NXP-2 (to be discussed #RNL24 Dr. Christopher-Stine) https://t.co/ZRlMPE48qX https://t.co/kxD1jw832C https://t.co/afC617tbmq
Sarcopenia Linked to Smoking in Osteoarthritis

Sarcopenia commonly has been linked to aging and arthritis and contribu

Dr. John Cush RheumNow

2 years 7 months ago
Sarcopenia Linked to Smoking in Osteoarthritis Sarcopenia commonly has been linked to aging and arthritis and contributes significantly to quality of life and outcomes, but the association between sarcopenia and OA has not been well established. https://t.co/anZMTGnFej https://t.co/TgVg3xpiWI
Biomarker Predicts Survival in Autoimmune Lung Disease

One major subgroup of patients with ILD arising from polymyosit

Dr. John Cush RheumNow

2 years 7 months ago
Biomarker Predicts Survival in Autoimmune Lung Disease One major subgroup of patients with ILD arising from polymyositis/dermatomyositis (PM/DM) survived significantly longer when serum levels of interferon-λ3 were relatively low, researchers found. https://t.co/PcTmzavJuC https://t.co/cNL3iTSGiF
Sarcopenia Linked to Smoking in Osteoarthritis

Sarcopenia commonly has been linked to aging and arthritis and contribu

Dr. John Cush RheumNow

2 years 7 months ago
Sarcopenia Linked to Smoking in Osteoarthritis Sarcopenia commonly has been linked to aging and arthritis and contributes significantly to quality of life and outcomes, but the association between sarcopenia and OA has not been well established. https://t.co/ucEWJjZ8Zv https://t.co/MeHw56vLjj
GNSC-001 gene therapy w/ a recombinant adeno-assoc. viral vector expressing IL-1Ra, to block IL-1. GNSC-001 now in a ph

Dr. John J Cush RheumNow

2 years 7 months ago

GNSC-001 gene therapy w/ a recombinant adeno-assoc. viral vector expressing IL-1Ra, to block IL-1. GNSC-001 now in a phase Ib, 50 pt, 10 center USA trial to assess its efficacy in Knee OA. Given as single injx in the affected joint; results in late 2024 https://t.co/jW9FHlGyC2 https://t.co/Dbv15Flqlv

Cross-sectional study of 307 RA pts, 49 (16%) used psychotropic meds and 70 (23%) had at least one fall per year. RA on

Dr. John Cush RheumNow

2 years 7 months ago
Cross-sectional study of 307 RA pts, 49 (16%) used psychotropic meds and 70 (23%) had at least one fall per year. RA on psychotropic meds had double the rate of falls (39% vs 20%). w/ an adjusted incidence rate ratio, 1.63. (p = 0.02). https://t.co/D1lhZj3he3
×